|
US7329725B1
(en)
*
|
2003-10-29 |
2008-02-12 |
Nastech Pharmaceutical Company Inc. |
Phage displayed Trp cage ligands
|
|
ES2563491T3
(es)
|
2004-07-06 |
2016-03-15 |
Bioren, LLC |
Bibliotecas universales de anticuerpos
|
|
CA2572917C
(en)
*
|
2004-07-06 |
2012-04-03 |
Bioren Inc. |
Look-through mutagenesis for developing altered polypeptides with enhanced properties
|
|
US20060024308A1
(en)
*
|
2004-07-06 |
2006-02-02 |
Roberto Crea |
High affinity anti-TNF-alpha antibodies and method
|
|
US20080207467A1
(en)
*
|
2005-03-03 |
2008-08-28 |
Xencor, Inc. |
Methods for the design of libraries of protein variants
|
|
US20060234303A1
(en)
*
|
2005-03-03 |
2006-10-19 |
Xencor, Inc. |
Methods for the design of libraries of protein variants
|
|
WO2006114700A2
(en)
*
|
2005-04-26 |
2006-11-02 |
Bioren, Inc. |
Method of producing human igg antibodies with enhanced effector functions
|
|
KR20080068004A
(ko)
*
|
2005-08-15 |
2008-07-22 |
아라나 테라퓨틱스 리미티드 |
뉴 월드 영장류 구조형성영역을 가진 조작 항체
|
|
US8716195B2
(en)
*
|
2005-11-14 |
2014-05-06 |
Bioren, Inc. |
Antibody ultrahumanization by predicted mature CDR blasting and cohort library generation and screening
|
|
WO2007086994A1
(en)
*
|
2005-11-15 |
2007-08-02 |
Balyasnikova Irina V |
Single chain fragment of monoclonal antibody 9b9 and uses thereof
|
|
AU2006326867A1
(en)
|
2005-12-20 |
2007-06-28 |
Cephalon Australia Pty Ltd |
Chimeric antibodies with part New World primate binding regions
|
|
US7846439B2
(en)
|
2006-02-01 |
2010-12-07 |
Cephalon Australia Pty Ltd |
Domain antibody construct
|
|
US7704953B2
(en)
*
|
2006-02-17 |
2010-04-27 |
Mdrna, Inc. |
Phage displayed cell binding peptides
|
|
WO2007112054A2
(en)
*
|
2006-03-23 |
2007-10-04 |
Sea Lane Biotechnologies, Llc |
Facilitation of translocation of molecules through the gastrointestinal tract
|
|
WO2007134327A2
(en)
|
2006-05-15 |
2007-11-22 |
Sea Lane Biotechnologies, Llc. |
Neutralizing antibodies to influenza viruses
|
|
WO2007136840A2
(en)
*
|
2006-05-20 |
2007-11-29 |
Codon Devices, Inc. |
Nucleic acid library design and assembly
|
|
WO2008020079A1
(en)
|
2006-08-18 |
2008-02-21 |
Ablynx N.V. |
Amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of deseases and disorders associated with il-6-mediated signalling
|
|
EP2069558B1
(en)
|
2006-10-02 |
2013-05-01 |
Sea Lane Biotechnologies,llc. |
Design and construction of diverse synthetic peptide and polypeptide libraries
|
|
EP2078077A2
(en)
*
|
2006-10-04 |
2009-07-15 |
Codon Devices, Inc |
Nucleic acid libraries and their design and assembly
|
|
CA2690055A1
(en)
*
|
2007-06-06 |
2008-12-18 |
Danisco Us Inc. |
Methods for improving protein performance
|
|
WO2009009045A2
(en)
*
|
2007-07-10 |
2009-01-15 |
The Scripps Research Institute |
Escape libraries of target polypeptides
|
|
US8680019B2
(en)
*
|
2007-08-10 |
2014-03-25 |
Protelica, Inc. |
Universal fibronectin Type III binding-domain libraries
|
|
US8470966B2
(en)
|
2007-08-10 |
2013-06-25 |
Protelica, Inc. |
Universal fibronectin type III binding-domain libraries
|
|
WO2009023184A2
(en)
*
|
2007-08-10 |
2009-02-19 |
Protelix, Inc. |
Universal fibronectin type iii binding-domain libraries
|
|
EP2650311A3
(en)
|
2007-11-27 |
2014-06-04 |
Ablynx N.V. |
Amino acid sequences directed against heterodimeric cytokines and/or their receptors and polypeptides comprising the same
|
|
JP2011516423A
(ja)
|
2008-03-28 |
2011-05-26 |
シー レーン バイオテクノロジーズ， エルエルシー |
ウイルス抗原に対する中和分子
|
|
EP2131243B1
(en)
*
|
2008-06-02 |
2015-07-01 |
ASML Netherlands B.V. |
Lithographic apparatus and method for calibrating a stage position
|
|
NZ595461A
(en)
|
2009-04-10 |
2013-01-25 |
Ablynx Nv |
Improved amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of il-6r related diseases and disorders
|
|
WO2010115995A2
(en)
|
2009-04-10 |
2010-10-14 |
Ablynx Nv |
Improved amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of il-6r related diseases and disorders
|
|
PT2438087T
(pt)
|
2009-06-05 |
2017-08-04 |
Ablynx Nv |
Construções de nanobody trivalentes de vírus sincicial respiratório humano (hrsv) para a prevenção e/ou tratamento de infeções do trato respiratório
|
|
SG10201700096VA
(en)
|
2009-07-17 |
2017-02-27 |
Bioatla Llc |
Simultaneous, Integrated Selection And Evolution Of Antibody/Protein Performance And Expression In Production Hosts
|
|
GB0914691D0
(en)
*
|
2009-08-21 |
2009-09-30 |
Lonza Biologics Plc |
Immunoglobulin variants
|
|
ES2691717T3
(es)
|
2009-10-30 |
2018-11-28 |
Novartis Ag |
Bibliotecas universales del dominio de unión del lado inferior de tipo iii de la fibronectina de tipo III
|
|
WO2011064382A1
(en)
|
2009-11-30 |
2011-06-03 |
Ablynx N.V. |
Improved amino acid sequences directed against human respiratory syncytial virus (hrsv) and polypeptides comprising the same for the prevention and/or treatment of respiratory tract infections
|
|
CN107903321A
(zh)
|
2010-07-30 |
2018-04-13 |
诺华有限公司 |
纤连蛋白摇篮分子和其库
|
|
JP5920835B2
(ja)
|
2010-12-01 |
2016-05-18 |
田辺三菱製薬株式会社 |
無細胞翻訳系でＦａｂを提示しうるポリヌクレオチド構築物ならびにそれを用いたＦａｂの製造方法およびスクリーニング方法
|
|
WO2013041722A1
(en)
|
2011-09-23 |
2013-03-28 |
Ablynx Nv |
Prolonged inhibition of interleukin-6 mediated signaling
|
|
EP2820043B1
(en)
|
2012-03-02 |
2020-01-15 |
Ablynx N.V. |
Biparatopic pseudomonas aeruginosa pcrv binding single variable domain antibodies
|
|
USRE49477E1
(en)
|
2012-04-20 |
2023-03-28 |
Thomas Jefferson University |
Engineered antibody for inhibition of fibrosis
|
|
NZ702030A
(en)
|
2012-05-25 |
2016-11-25 |
Chr Hansen As |
Variants of chymosin with improved milk-clotting properties
|
|
WO2014087010A1
(en)
|
2012-12-07 |
2014-06-12 |
Ablynx N.V. |
IMPROVED POLYPEPTIDES DIRECTED AGAINST IgE
|
|
WO2014092458A1
(ko)
*
|
2012-12-11 |
2014-06-19 |
연세대학교 산학협력단 |
코돈 조합화 및 변이유발을 이용한 유전자 라이브러리의 합성 방법
|
|
US20140314741A1
(en)
*
|
2013-04-18 |
2014-10-23 |
Developmen Center For Biotechnology |
Human Antibody against Interleukin-20 and Treatment for Inflammatory Diseases
|
|
US9416197B2
(en)
|
2013-11-01 |
2016-08-16 |
Ibc Pharmaceuticals, Inc. |
Bispecific antibodies that neutralize both TNF-α and IL-6: novel therapeutic agent for autoimmune disease
|
|
CN104805507B
(zh)
*
|
2014-01-29 |
2019-01-22 |
杭州康万达医药科技有限公司 |
噬菌体展示文库及其应用和制备方法
|
|
RU2717770C2
(ru)
|
2014-02-26 |
2020-03-25 |
Кхр. Хансен А/С |
Варианты химозина с улучшенными молокосвертывающими свойствами
|
|
CA2963712A1
(en)
|
2014-10-21 |
2016-04-28 |
Ablynx Nv |
Treatment of il-6r related diseases
|
|
RU2740317C2
(ru)
|
2015-06-22 |
2021-01-13 |
Кхр. Хансен А/С |
Варианты химозина с улучшенными свойствами
|
|
EP3344049A1
(en)
|
2015-08-31 |
2018-07-11 |
Chr. Hansen A/S |
Variants of chymosin with improved properties
|
|
US11484592B2
(en)
*
|
2016-01-08 |
2022-11-01 |
Momotaro-Gene Inc. |
Combination therapy using REIC/Dkk-3 gene and a checkpoint inhibitor
|
|
EP3457859A1
(en)
|
2016-05-19 |
2019-03-27 |
Chr. Hansen A/S |
Variants of chymosin with improved milk-clotting properties
|
|
US10961524B2
(en)
|
2016-05-19 |
2021-03-30 |
Chr. Hansen A/S |
Variants of chymosin with improved milk-clotting properties
|
|
ES2981703T3
(es)
|
2016-09-02 |
2024-10-10 |
Lentigen Tech Inc |
Composiciones y métodos para tratar cáncer con DuoCars
|
|
US11891426B2
(en)
|
2017-12-15 |
2024-02-06 |
Aleta Biotherapeutics Inc. |
CD19 variants
|